SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
African Heads of State Commit to Advancing Immunization in Africa
February 01, 2017
Novo Nordisk and Oxford University Collaborate on Diabetes Research
January 31, 2017
China Expands Drug Formulary
FDA Highlights the Importance of Confirmatory Studies
January 30, 2017
FDA Moves Forward with Inspection Overhaul
January 25, 2017
New Partnership to Provide Co-Pay Assistance Programs to Consumers
January 20, 2017
Colorectal Cancers Market to Approach $11 Billion by 2025
January 24, 2017
European Commission Publishes Biosimilars Q&A for Patients
January 23, 2017
Astellas Signs Up for Access Accelerated
January 19, 2017
NICE Delays Drug Appraisal Fee Plan
Daiichi Sankyo Closes Indian Research Division
January 18, 2017
OECD Ministerial to Address Next Generation of Health Reforms
January 16, 2017
AstraZeneca Appoints New Head of Oncology
January 12, 2017
Pharma Companies Align for New Industry Standards Group
January 11, 2017
Global Pharma and Biotech M&A "Feels the Heat" in 2016
The Good, the Bad, and the Donald: CPhI Worldwide Expert Panel's Pharma Predictions 2017
January 10, 2017
Takeda to Acquire ARIAD Pharmaceuticals
Foundation Medicine Taps Genentech Veteran as CEO
January 09, 2017
J&J Announces 15 New Collaborations
January 06, 2017
New CEO for Amplyx Pharmaceuticals
The ‘Healthcare Internet of Things’
Connected ecosystems will change the future of healthcare. William King outlines three key value drivers.
FDA's Criminal Investigation Head to Leave as Trump Takes Office
January 04, 2017
Drug and Gene Delivery Systems Market Worth $786.9 Billion by 2025
January 03, 2017
The State of Market Insights in Pharma
It's time to take advantage of a nascent technology embrace taking hold among market insights professionals.
"Significant Unmet Needs" Remain in Hepatitis C
December 22, 2016
Medical Game-Changers Beckon
Cleveland Clinic looks at the big medical innovations in store for 2017.
Healthcare Industry "Bracing for Drastic Changes Under Trump Administration"
December 21, 2016
EMA Launches Biosimilars Project
December 20, 2016
US Molecular Diagnostics Market to Reach $6.55 Billion by 2021
December 19, 2016
ImmunoCellular Therapeutics Names New CEO
December 16, 2016